Crystal structure of 2-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)benzaldehyde, C13H13O3N3S

Mokete A. Motente; Uche A.K. Chude-Okonkwo; Orpah Zinyemba; Dumisane V. Kama

doi:10.1515/ncrs-2025-0364

Crystal structure of 2-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)benzaldehyde, C₁₃H₁₃O₃N₃S

Mokete A. Motente, Uche A.K. Chude-Okonkwo, Orpah Zinyemba, Dumisane V. Kama

Electrical and Electronic Engineering Science

Research output: Contribution to journal › Article › peer-review

Abstract

C₁₃H₁₃O₃N₃S, monoclinic, Pn (no. 7), a = 6.9318(5) Å, b = 12.0202(8) Å, c = 7.8080(6) Å, β = 98.469(3)°, V = 643.50(8) Å³, Z = 2, R_gt(F) = 0.0906, wR_ref(F²) = 0.0914, T = 100 K.

Original language	English
Journal	Zeitschrift fur Kristallographie - New Crystal Structures
DOIs	https://doi.org/10.1515/ncrs-2025-0364
Publication status	Accepted/In press - 2025

ASJC Scopus subject areas

General Materials Science
Condensed Matter Physics
Inorganic Chemistry

Access to Document

10.1515/ncrs-2025-0364

Cite this

@article{3aeba5cfc62347e8a33c07ef4ec4c3d1,

title = "Crystal structure of 2-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)benzaldehyde, C13H13O3N3S",

abstract = "C13H13O3N3S, monoclinic, Pn (no. 7), a = 6.9318(5) {\AA}, b = 12.0202(8) {\AA}, c = 7.8080(6) {\AA}, β = 98.469(3)°, V = 643.50(8) {\AA}3, Z = 2, Rgt(F) = 0.0906, wRref(F2) = 0.0914, T = 100 K.",

author = "Motente, \{Mokete A.\} and Chude-Okonkwo, \{Uche A.K.\} and Orpah Zinyemba and Kama, \{Dumisane V.\}",

note = "Publisher Copyright: {\textcopyright} 2025 the author(s), published by De Gruyter, Berlin/Boston.",

year = "2025",

doi = "10.1515/ncrs-2025-0364",

language = "English",

journal = "Zeitschrift fur Kristallographie - New Crystal Structures",

issn = "1433-7266",

publisher = "Walter de Gruyter GmbH",

}

TY - JOUR

T1 - Crystal structure of 2-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)benzaldehyde, C13H13O3N3S

AU - Motente, Mokete A.

AU - Chude-Okonkwo, Uche A.K.

AU - Zinyemba, Orpah

AU - Kama, Dumisane V.

PY - 2025

Y1 - 2025

N2 - C13H13O3N3S, monoclinic, Pn (no. 7), a = 6.9318(5) Å, b = 12.0202(8) Å, c = 7.8080(6) Å, β = 98.469(3)°, V = 643.50(8) Å3, Z = 2, Rgt(F) = 0.0906, wRref(F2) = 0.0914, T = 100 K.

AB - C13H13O3N3S, monoclinic, Pn (no. 7), a = 6.9318(5) Å, b = 12.0202(8) Å, c = 7.8080(6) Å, β = 98.469(3)°, V = 643.50(8) Å3, Z = 2, Rgt(F) = 0.0906, wRref(F2) = 0.0914, T = 100 K.

UR - https://www.scopus.com/pages/publications/105019693803

U2 - 10.1515/ncrs-2025-0364

DO - 10.1515/ncrs-2025-0364

M3 - Article

AN - SCOPUS:105019693803

SN - 1433-7266

JO - Zeitschrift fur Kristallographie - New Crystal Structures

JF - Zeitschrift fur Kristallographie - New Crystal Structures

ER -

Crystal structure of 2-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)benzaldehyde, C₁₃H₁₃O₃N₃S

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this